Revenue
2022
2023
2024
2025
Park Ha Biological Technology Co., Ltd. (BYAH)
Price—Loading quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $2.5M | $2.4M | $2.5M | $1.9M |
| Gross profit | $2.4M | $2.2M | $2.1M | $1.4M |
| Research & development | $238,184 | $36,714 | $30,881 | $60,671 |
| Operating expenses | $26.5M | $1.4M | $967,559 | $1.2M |
| Operating income | −$24.1M | $793,714 | $1.2M | $197,024 |
| EBITDAderived | −$24.0M | $816,400 | $1.2M | $227,515 |
| Net income | −$24.4M | $478,561 | $852,042 | $191,298 |
| Basic EPSper diluted share | -$41.38 | $0.96 | $1.70 | $0.01 |
| Diluted EPSper diluted share | -$41.38 | $0.96 | $1.70 | $0.01 |